|
Volumn 3, Issue 1, 2003, Pages 5-7
|
Polymorphic CYP2A6 and its clinical and toxicological significance
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3,5 DIMETHYL 2 (3 PYRIDYL) 4 THIAZOLIDINONE;
AFLATOXIN B1;
ALKALOID;
ANTICONVULSIVE AGENT;
COTININE;
CYTOCHROME P450 2A6;
FADROZOLE;
FLUOROURACIL;
NICOTINE;
NITROSAMINE;
TEGAFUR;
CANCER RISK;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG METABOLISM;
ETHNIC DIFFERENCE;
GENE CLUSTER;
GENE DELETION;
GENE FREQUENCY;
GENE STRUCTURE;
GENETIC ORGANIZATION;
GENETIC POLYMORPHISM;
GENETIC TOXICOLOGY;
GENETIC VARIABILITY;
GENOTYPE;
HUMAN;
LUNG CANCER;
NOTE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SINGLE NUCLEOTIDE POLYMORPHISM;
SMOKING HABIT;
STOMACH CANCER;
ARYL HYDROCARBON HYDROXYLASES;
HUMANS;
MIXED FUNCTION OXYGENASES;
PHARMACOGENETICS;
POLYMORPHISM, GENETIC;
|
EID: 0037247694
PISSN: 1470269X
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.tpj.6500154 Document Type: Note |
Times cited : (12)
|
References (14)
|